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Abstract
Background: Most individuals at risk for developing cardiovascular disease (CVD) can reduce risk
factors through diet and exercise before resorting to drug treatment. The effect of a combination
of resistance training with vegetable-based (soy) versus animal-based (whey) protein
supplementation on CVD risk reduction has received little study. The study's purpose was to
examine the effects of 12 weeks of resistance exercise training with soy versus whey protein
supplementation on strength gains, body composition and serum lipid changes in overweight,
hyperlipidemic men.
Methods: Twenty-eight overweight, male subjects (BMI 25–30) with serum cholesterol >200 mg/
dl were randomly divided into 3 groups (placebo (n = 9), and soy (n = 9) or whey (n = 10)
supplementation) and participated in supervised resistance training for 12 weeks. Supplements
were provided in a double blind fashion.
Results: All 3 groups had significant gains in strength, averaging 47% in all major muscle groups and
significant increases in fat free mass (2.6%), with no difference among groups. Percent body fat and
waist-to-hip ratio decreased significantly in all 3 groups an average of 8% and 2%, respectively, with
no difference among groups. Total serum cholesterol decreased significantly, again with no
difference among groups.
Conclusion: Participation in a 12 week resistance exercise training program significantly increased
strength and improved both body composition and serum cholesterol in overweight,
hypercholesterolemic men with no added benefit from protein supplementation.
Background
Resistance exercise is a popular training method,
approved by major medical groups including the Ameri-
can Heart Association, the American College of Sports
Medicine [1,2] to increase muscle mass and improve
blood lipid profiles. It is common for males to consume
commercial protein supplements and use high intensity
resistance training to develop "muscle bulk" for reasons of
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physical appearance, competition, and/or strength gains.
Sedentary individuals may also participate in resistance
training to improve physical appearance, but many initi-
ate weight lifting programs with the goal of improving
overall health and fitness. It is well documented that lean
muscle mass plays a significant role in determining basal
metabolic rate and, thus, daily energy expenditure [3].
Creating and maintaining sites of ATP turnover and
enhancing metabolic expenditure through resistance
training can help prevent an age-associated decline in
metabolic rate and undesirable gains in fat mass [2,4,5]. A
high percentage of body fat is associated with hyperlipi-
demia, a known cardiovascular disease (CVD) risk factor
[3]. Given that the relative risk of CVD for physically inac-
tive individuals versus active individuals is 1.5–2.4 and
that 60% of U.S. adults do not participate in regular phys-
ical activity [6], the benefit of resistance exercise in reduc-
ing CVD risk is widely recognized and is supported by all
major health organizations [2,7]. Promoting the benefits
and encouraging participation in this low-cost activity
could help prevent CVD and other behavior-driven
chronic diseases, and may provide significant cost-savings
to an over-burdened health care system.
Amino acid availability is an important regulator of mus-
cle protein metabolism during resistance training exercise
[8]. Muscle net protein balance must be positive (greater
muscle protein synthesis than breakdown) to experience
an increase in muscle mass, which occurs only when suf-
ficient amino acids are available in the intracellular pool.
Whey and soy are both high quality sources of protein and
popular supplements in the exercise community. It has
been suggested soy supplementation may reduce CVD
risk, a benefit that consumption of whey protein does not
provide. Both proteins are easily digestible and have sim-
ilar absorption kinetics [9], but some controversy exists
whether soy will support skeletal muscle protein accretion
in response to resistance training as effectively as whey.
Phillips et al [10] reported that whey was superior to soy
in stimulating amino acid uptake during a resistance
training program. More recently Anthony et al [9]
observed similar protein synthesis rates in exercised skele-
tal muscle in rats who ingested either whey or soy protein.
In addition, several human studies observed no differ-
ences in either strength gains or increases in lean mass in
resistance trained subjects who supplemented their diets
with either soy or whey [10-13].
While supplementation with whey protein is popular
with weight lifting enthusiasts, mainly to promote gains
in muscle size, supplementing with soy protein is not as
common. But, because of its potential to improve blood
lipid profiles [14-16] soy consumption may be more
appealing to a sub-set of exercisers – those at moderate or
high risk for CVD. Soy's non-essential amino acid content
favors post-prandial production of glucagon, which, as
opposed to insulin, down-regulates lipogenic enzymes
and lowers cholesterol synthesis [17]. Soy also has a
number of other physiologically active compounds with
cholesterol-lowering properties such as isoflavones, fiber,
and phytoestrogens [14,15,18,19]. Soy protein supple-
mentation in combination with resistance training may
promote protein (or muscle) anabolism to the same
extent as supplementation with whey protein [12,20,21];
so the plant-based protein's potential to lower blood lip-
ids and reduce oxidative stress may provide a simple, cost-
effective means of reducing cardiovascular disease risk.
The purpose of this study was to document changes in
strength, body composition, and blood lipid profiles in
sedentary, overweight, hypercholesterolemic male sub-
jects who participated in a 12-week resistance training
program and who supplemented their usual diets with
either whey or soy protein versus placebo. It was hypoth-
esized that: 1) subjects receiving either protein supple-
ment would have equivalent gains in both strength and
lean body mass and these gains would be greater than the
placebo group; 2) Subjects receiving the soy supplementa-
tion would have a significant reduction in fasting blood
lipid levels versus the whey and placebo groups.
Methods
Subjects
Thirty two healthy males from the Western New York
community volunteered to participate in the study. These
men (age range 21–50 years; mean 38) were generally sed-
entary, overweight [BMI (body mass index) 25.0–29.9],
with mild to moderate hypercholesterolemia, but other-
wise in overall good health. Inclusion criteria of a general
sedentary lifestyle ensured that no participant recorded a
BMI above 25.0 due to significant muscle mass at the
beginning of the study period. Each subject was informed
of the purpose and procedures of the study, and provided
informed consent in accordance with the Human Sub-
ject's Review Committee of the University at Buffalo. Cri-
teria for inclusion were: sedentary lifestyle (none or
minimal routinely planned physical activity); BMI
between 25.0–29.9; normal fasting blood glucose; and
two or more of the following CVD risk factors: total cho-
lesterol 200–240 mg/dl, LDL cholesterol 130–160 mg/dl,
or triglycerides 150–200 mg/dl. Exclusion criteria
included any prior cerebrovascular event that required
hospitalization or surgery, habitual soy consumers, smok-
ers, orthopedic or neuromuscular disorders that pre-
cluded participation in resistive exercise training and
medications that affect lipid metabolism, blood pressure
or cardiac function.
Anthropometrics
Each subject's height was measured using a stadiometer
(Perspective Enterprises, Kalamazoo, Michigan) and body
mass was measured on a Health-O-Meter scale (Brid-Journal of the International Society of Sports Nutrition 2009, 6:8 http://www.jissn.com/content/6/1/8
Page 3 of 9
(page number not for citation purposes)
geview, Illinois). Skinfolds (tricep, supraillium, abdomen
and thigh) were measured with Lange skinfold calipers
(Cambridge Scientific Industries, Inc., Cambridge, Mary-
land). All skinfolds were measured by the same investiga-
tor utilizing the same caliper for each study subject.
Measures were taken in triplicate with a 2 mm reliability
range. Final skinfolds were taken without viewing initial
measures to minimize experimentation bias. Percent
body fat was then estimated using the 4-site formula from
ACSM's Resource Manual for Guidelines for Testing and
Prescription [22]. Body Mass Index was calculated as body
mass in kilograms divided by height in meters squared
(kg/m2). Waist and hip circumferences were measured
using a gulick measuring tape having a calibrated tension
device to the nearest .25 inch. Waist measurements were
taken at the minimal circumference of the abdomen and
hip circumference was measured at the maximal gluteal
protrusion of the buttocks. Fat free mass was calculated as
body weight minus fat mass.
Diet Analysis
During the initial screening process subjects were
instructed by a registered dietitian how to maintain
proper 3-day food records. Each subject completed a food
record prior to beginning the exercise program and at the
end of each exercise block (every 3 weeks) for a total of 5
diet records throughout the study. Records were analyzed
utilizing Nutritionist Pro software (First Databank, San
Bruno, CA). Based on data from diet records, the regis-
tered dietitian provided feedback to assist each subject in
maintaining a protein intake equivalent between groups
to approximate 1.2 g/kg body mass/day (including the
supplement).
Experimental Protocol
Subjects were initially screened by a phone interview and
eligible candidates were invited to visit the laboratory,
after a 12-hour fast. Potential subjects obtained additional
information about the study and reviewed and signed
informed consent. Subjects provided a blood sample for a
blood lipid profile and blood glucose concentration The
lipid profile included total cholesterol, high and low den-
sity lipoprotein cholesterol (HDL-C and LDL-C, respec-
tively), and triglycerides using the Cholestech L· D·X®
(Cholestech Corporation, Hayward, CA). Height and
body mass were measured to calculate BMI. If the inclu-
sion criteria were met the participant was scheduled for a
baseline blood draw in The Center for Preventive Medi-
cine at the University at Buffalo, after a 12 hour fast
(except for water) and after abstaining from caffeine, alco-
hol and exercise for the previous 24 hours. During this
visit, body composition was measured and each subject
was given diet record forms and instructed on proper
completion. Subjects were also instructed how to mix
(with 8 oz water or fruit juice) and to consume individual
protein packets on a daily basis. Subjects were instructed
that the timing of consumption of the supplement was
critical. On workout days the supplement was to be taken
within 60 minutes of the scheduled workout and on "off"
days, at approximately the same time of day as the work-
out days. Subjects were instructed to limit other soy con-
taining products in their diet as well as to maintain
protein intakes as close to 1.2 g/kg body mass/day as pos-
sible (from feedback given after analysis of each of the five
3-day diet records). The resistance exercise program was
reviewed and each subject underwent a medical evalua-
tion by a physician to determine appropriateness to par-
ticipate in the study.
Experimental Groups
A double-blind protocol was used in this study whereby
subjects were randomly assigned to one of three experi-
mental groups: RES = resistance training with carbohy-
drate placebo; SOY = soy supplementation (25.8 g soy
protein/day containing 56.2 mg isoflavones, expressed as
aglycone equivalent) + resistance training; WHEY = whey
supplementation (26.6 g whey protein/day) + resistance
training. Coded supplements were kindly supplied by
Solae LLC (St. Louis, MO) and were prepared for distribu-
tion by a trained individual not involved with any other
part of the study. The formulation was developed for max-
imum protein delivery with minimum caloric content.
The placebo contained 25 grams of complex carbohy-
drates (Table 1).
Table 1: Supplement composition (each packet 36.5 grams)1
Nutrient Whey Soy Placebo
Kilocalories 130.0 130.0 122.4
Protein (g) 26.6 25.8 0.6
Protein (%) 73.0 70.7 1.54
Total carbohydrate (g) 5.0 5.0 30.0
Fat, acid hydrolysis (%) 2.54 1.66 N/D2
Isoflavones (mg/g product)
Total isoflavones -3 2.65 -3
Genistein-containing compounds -3 1.48 -3
Daidzein-containing compounds -3 1.03 -3
Glycitein-containing compounds -3 0.14 -3
Total aglycone equivalents -3 1.54 -3
Genistein -3 0.86 -3
Daidzein -3 0.60 -3
Glycitein -3 0.08 -3
Ash (%) 10.1 11.4 10.3
Moisture (%) 3.6 2.7 4.2
1only significant levels listed
2not detectable
3contains no isoflavones
Information provided by Solae LLC, St. Louis, MOJournal of the International Society of Sports Nutrition 2009, 6:8 http://www.jissn.com/content/6/1/8
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Blood Analysis
Blood samples were taken at baseline, prior to entering
into the exercise program, and at the end of the 12 weeks
of training. A total of 21 ml of blood was drawn. Seven ml
were placed into a plasma tube containing an anticoagu-
lant agent (K3EDTA) and the remaining 14 ml was split
between 2 serum tubes with no anticoagulant. The plasma
tube was immediately placed on ice, while serum tubes
were left to stand at room temperature for 30 minutes to
allow for clotting. All samples were centrifuged at 4°C,
1500 × g for 10 minutes, then aliquoted and stored at -
80°C until analyzed.
Blood levels of cholesterol (total, LDL and HDL) and trig-
lycerides were analyzed by enzymatic procedures (WAKO
Chemicals USA, Richmond, VA). Assays for each subject
were run in duplicate on the same day with the same rea-
gent batch. External calibrators were included on every
run and the concentrations in the calibration curves
encompassed the range of expected sample values. Two
lyophilized quality control materials were run throughout
the duration of each test to estimate intra-assay reproduc-
ibility.
Resistance Training
Subjects began resistance training under the supervision
of experienced trainers soon after their first blood draw.
Subjects were required to refrain from any other exercise
training to minimize confounding variables. Supervised
exercise sessions were identical for each subject and were
held on a 3-day-a-week cycle (48–72 hours between ses-
sions) for a total of 12 weeks that included 4 exercise
blocks. Each exercise block was 21 days in duration and
provided a progressive training program (Table 2). This
program was based on a similar 12-week resistance train-
ing program that produced significant increases in
strength and lean body mass in males [23]. Trainers
instructed subjects on proper form for each exercise to
minimize variation in exercise technique. For each exer-
cise, a 4 second count was used for the concentric phase
and a 2 second count for the eccentric phase. Exercises
were designed to include major muscles in the upper arm,
chest, back, legs, shoulder and abdomen (Table 3).
A one-repetition maximum (1-RM) was calculated as rec-
ommended by The American College of Sports Medicine
[24] using the Brzycki regression equation, {1 RM =
weight lifted during n RM/(1.0278-.0278(n)}, at the
beginning of the study and each exercise block (week 1, 4,
7, 10), as a measure of strength. Subjects were required to
participate in > 80% of exercise sessions over the 12 week
period. Training logs for each subject were kept by
assigned trainers.
Statistical Analysis
To evaluate the effects of resistance training and protein
supplementation on changes in strength and body com-
position a two-way repeated-measures analysis of vari-
ance design was utilized (Sigma Stat 3.0). The Tukey's test
for multiple comparisons was then conducted. P < 0.05
was considered significant.
Results
Over the course of the study, three subjects dropped out
because of the inability to schedule training sessions
between employment demands and outside interests.
One individual ceased participation due to relocation.
Twenty-eight subjects completed the study and were
included in the final statistical analysis.
Physical Characteristics
The three groups resembled each other in most baseline
physical characteristics of body weight, BMI, percent body
fat, fat mass, and fat free mass. The soy group had an over-
all higher waist-to-hip ratio versus the whey group but
neither group was different from the placebo group. All
groups demonstrated a significant reduction (as per cent
decrease) in waist-to-hip ratio (1.1%, p < 0.05), percent
body fat (8.29%, p < 0.001) and fat mass (8.1%, p <
0.001) and a significant increase in fat free mass (2.6%, p
< 0.001) over the course of the study, with no difference
among groups (Table 4). As expected, there was no signif-
icant change in body weight or BMI.
Nutritional intake
Energy, macronutrient, cholesterol, dietary fiber; and
alcohol intakes pre-and post-study are shown in Table 5.
Total energy consumption, total carbohydrate, total fat,
saturated, monounsaturated, and polyunsaturated fatty
acids, total cholesterol, dietary fiber, and alcohol did not
differ significantly among treatment groups over the 12
weeks of the study. Total dietary protein, grams/kg body
weight protein, percent of energy from protein, and per-
cent of energy from carbohydrates were all significantly
greater post versus pre-study (p < 0.05), but percent of
energy from fat was significantly lower (p < 0.05).
Strength
All groups experienced a significant increase in strength
(average increase = 47%, p < 0.001) (Table 6) with no sig-
nificant differences among groups. All major muscle
Table 2: Resistance training cycle/schedule
Reps Sets Rest btw Sets Total Days
Block 1 8–10 2–3 1 min 21
Block 2 8–10 3–4 1 min 21
Block 3 10–12 3 up to 1 min 21
Block 4 10–12 4 up to 1 min 21Journal of the International Society of Sports Nutrition 2009, 6:8 http://www.jissn.com/content/6/1/8
Page 5 of 9
(page number not for citation purposes)
groups including chest, triceps, back, legs, shoulder, abdo-
men and biceps showed an increase in strength.
Serum Lipids
Twelve weeks of resistance exercise resulted in a signifi-
cant (average = 5.8%) decrease in fasting total cholesterol
for all groups (mean reduction = 12.6 mg/dL, ± 4.5) with
no differences among groups (Table 7). However, no sig-
nificant changes in triglycerides, HDL-C, or TC:HDL-C
were observed in any of the groups.
Discussion
The principle findings of this study were that 12 weeks of
resistance exercise training significantly increased muscle
strength and fat free mass and significantly decreased
waist-to-hip ratio, percent body fat, and total serum cho-
lesterol in overweight, hyperlipidemic men. All groups
had an equal reduction in total cholesterol, although the
ratio of LDL cholesterol to HDL cholesterol tended to
improve more in the soy group. These results provide fur-
ther support for a structured resistance training program
to improve strength and the cardiovascular risk profile of
sedentary, overweight adult men desiring to improve their
overall health.
Although no significant differences were observed among
groups in total cholesterol and HDL-C after 12 weeks of
resistance training, the soy group showed a tendency to
improve both TC:HDL-C and LDL-C:HDL-C. These values
were 2.5 and 2.0 times those of the whey group, respec-
tively. These ratios are important variables in the predic-
tion of CVD risk [25-27]. HDL-C levels are inversely
related to CVD risk because HDL-C inhibits LDL oxida-
tion (central to the initiation and progression of athero-
sclerosis) and reverses cholesterol transport [28,29].
Though all experimental groups demonstrated an equal
reduction in total cholesterol, it may be relevant that
ratios of LDL cholesterol to HDL cholesterol improved
more in the soy group.
Regional distribution of fat is an important risk factor for
cardiovascular disease with central (abdominal) fat
deposits posing higher risk [2]; therefore our finding of a
reduction in waist to hip ratio is of significant importance.
The average reductions in waist and hip circumferences
were 1.4 inches and 1 inch, respectively. These reductions
are not likely the result of dietary changes as there were no
significant changes in total calories, total fat or body
weight over the course of the 12-week study. This finding
supports previous studies that show resistance training
decreases abdominal adiposity and reduces the waist-to-
hip ratio, although total body weight changes may be
small [5,8,14]. Banz et al. [1] and Ibanez et al. [14] dem-
onstrated a significant reduction in waist-to-hip ratio and
total body fat after subjects were placed on 10 and 16
weeks of resistance exercise sessions, respectively. Camp-
bell et al. [30] also saw significant reductions in percent
body fat and fat mass and a significant increase in fat free
mass after 12 weeks of resistance training with subjects
either on a low protein diet (0.8 g/kg/day) or on a higher
Table 3: Resistance training: muscle groups & assigned exercises
Muscles Involved Exercise
Day 1 workout chest, triceps bench press; squats, dumbbell bench press, shoulder press, over head press
Day 2 workout back, legs, and biceps bent over rows, lunges, 1 arm rows, upright rows, back extensions
Day 3 workout legs, shoulder, abdominal flys, step-ups, shrugs, abdominal crunches, lateral raises
Table 4: Body composition measures.
PLACEBO1 WHEY1 SOY1 P-value
PRE2 POST2 PRE2 POST2 PRE2 POST2 PRE vs. POST3
Body Wt (kg) 89.9 ± 3.0 90.0 ± 3.0 90.0 ± 4.4 89.5 ± 4.5 92.9 ± 2.5 93.5 ± 2.5 NS4
BMI (kg/m2) 27.9 ± 0.4 27.9 ± 0.5 28.5 ± 0.7 28.4 ± 0.8 29.4 ± 0.8 29.6 ± 0.7 NS
Waist/Hip 0.90 ± 0.010ab 0.89 ± 0.010 0.88 ± 0.015a 0.86 ± 0.020 .93 ± 0.015b 0.92 ± 0.013 0.034
% Body Fat 22.9 ± 1.0 20.4 ± 0.9 23.0 ± 1.0 21.3 ± 1.0 24.2 ± 1.0 22.7 ± 1.0 <0.001
Fat Mass (kg) 20.6 ± 1.2 18.4 ± 1.0 21.0 ± 1.9 19.3 ± 1.7 22.5 ± 1.3 21.3 ± 1.3 <0.001
Fat Free Mass (kg) 69.2 ± 2.5 71.6 ± 2.4 68.9 ± 2.8 70.1 ± 3.1 70.3 ± 1.8 72.1 ± 1.7 <0.001
Pre- and post-study.
1All values are averages ± SEM; n = 9 for placebo, n = 9 for whey, n = 10 for soy.
2 Pre = baseline, prior to exercise and supplementation; post = end of 12 weeks.
3 Only the P value for pre versus post, with diet groups combined are presented, since diet effects were not significant and there was no interaction 
between diet and time (pre versus post).
ab Values with a common superscript are not significantly different, at baseline (P < 0.05).
4NS, P > 0.0.Journal of the International Society of Sports Nutrition 2009, 6:8 http://www.jissn.com/content/6/1/8
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protein diet (1.62 g/kg/day) diet. Our findings agree with
these studies in that major changes in body weight or BMI
were not observed, despite significant reductions in fat
mass and adiposity. Body weight and BMI typically do not
change because of concomitant increases in muscle mass
and reductions in fat mass. These results, combined with
others, demonstrate the limitations inherent in using
changes in BMI and body weight to track the benefits of
weight management programs.
Also consistent with previous studies [1,23,30], we dem-
onstrated a significant accretion in muscle mass in a rela-
tively short time. The ability to maintain or increase lean
body mass, especially given the progressive decline in
muscle mass that normally accompanies aging, is an
important contributor to lowering cardiovascular disease
risk [20,29]. While the use of whey supplementation to
support muscle hypertrophy has been the topic of many
studies, the ability of soy protein to support lean body
Table 5: 3-day food intake
PLACEBO1 WHEY1 SOY1
PRE2 POST2 PRE2 POST2 PRE2 POST2 PRE vs. POST P 
value3
Total Kcal/d 1976.5 ± 111.0 2062.1 ± 125.3 2205.6 ± 270.1 2405.0 ± 135.7 2155.6 ± 297.1 2283.1 ± 291.0 NS
Total Protein (g)/d 86.1 ± 13.9 93.7 ± 18.6 97.6 ± 14.7 116.1 ± 18.2 85.3 ± 25.5 108.2 ± 22.8 0.013
Protein (g/kg BW)/
d
1.0 ± 0.2 1.0 ± 0.2 1.0 ± 0.5 1.2 ± 0.3 0.92 ± 0.3 1.1 ± 0.3 0.012
Total Protein 
(% energy)
17.3 ± 2.4 19.3 ± 3.8 17.7 ± 4.2 19.5 ± 3.0 16.3 ± 4.4 20.7 ± 5.7 0.010
Total CHO (g)/d 228.8 ± 19.0 244.8 ± 21.8 267.4 ± 26.6 316.3 ± 19.7 230.3 ± 39.6 243.9 ± 27.0 NS
Total CHO 
(% energy)
45.7 ± 8.7 49.3 ± 7.3 49.5 ± 10.7 52.6 ± 7.8 41.8 ± 10.4 44.0 ± 7.1 0.031
Total Fat (g)/d 75.6 ± 20.5 66.1 ± 19.0 81.4 ± 48.3 76.0 ± 28.5 84.6 ± 38.8 77.7 ± 35.1 NS
Total Fat 
(% energy)
33.9 ± 7.1 30.1 ± 6.3 31.5 ± 7.8 27.5 ± 7.5 34.7 ± 7.8 30.0 ± 6.6 0.005
Saturated Fat (g) 25.4 ± 6.4 20.5 ± 5.8 26.8 ± 18.3 24.7 ± 10.2 27.9 ± 10.6 27.1 ± 12.8 NS
MUFA(g) 19.8 ± 10.6 17.4 ± 7.5 21.7 ± 11.3 19.6 ± 8.5 27.7 ± 16.5 20.0 ± 12.2 NS
PUFA (g) 10.9 ± 6.7 10.8 ± 5.2 10.7 ± 5.9 12.4 ± 8.0 12.3 ± 10.6 12.4 ± 8.7 NS
Total Cholesterol 
(mg)
245.7 ± 131.2 287.2 ± 118.6 295.9 ± 203.2 269.4 ± 153.9 228.3 ± 121.8 235.1 ± 75.6 NS
1All values are averages ± SEM; n = 9 for placebo, n = 9 for whey, n = 10 for soy.
2Pre = values are based on results of one 3-day intake study completed at baseline, prior to exercise and supplementation; post = end of 12 weeks.
3 Only the value for pre versus post, with diet groups combined, since the diet effects were not significant and there was no interaction between 
diet and time (pre versus post).
4NS, P > 0.05; BW, body weight.
Table 6: Strength changes
PLACEBO1 WHEY1 SOY1
PRE2 POST2 PRE2 POST2 PRE2 POST2 PRE vs. POST P value3
Bench Press 72.8 ± 5.9 90.3 ± 7.5 72.4 ± 8.7 89.8 ± 8.7 74.3 ± 8.1 92.5 ± 6.5 <0.001
Squats 77.5 ± 9.0 111.2 ± 13.5 75.7 ± 8.7 115.1 ± 10.0 77.1 ± 5.5 116.0 ± 6.9 <0.001
DB Bench Press 24.6 ± 2.1 34.0 ± 2.7 24.0 ± 3.2 34.9 ± 3.1 28.1 ± 3.3 36.2 ± 3.2 <0.001
Shoulder Press 15.4 ± 1.4 24.0 ± 2.1 16.9 ± 2.4 27.6 ± 4.6 17.9 ± 2.9 23.3 ± 1.9 <0.001
Triceps 16.6 ± 1.5 28.8 ± 2.3 19.3 ± 3.3 30.2 ± 3.5 19.3 ± 2.0 28.6 ± 2.9 <0.001
Bent-Over-Row 57.3 ± 7.1 77.4 ± 5.7 55.5 ± 7.0 82.0 ± 7.2 52.8 ± 4.5 73.6 ± 3.2 <0.001
Lunges 41 ± 4.0 78.5 ± 4.8 51.6 ± 8.2 85.8 ± 9.7 43.2 ± 3.9 73.7 ± 5.9 <0.001
1 Arm Row 27.6 ± 3.0 38.9 ± 3.2 24.5 ± 3.4 40.3 ± 2.8 29.2 ± 3.5 41.8 ± 2.5 <0.001
Upright Row 43 ± 3.8 55.3 ± 3.2 46.7 ± 5.5 63.8 ± 5.8 41.2 ± 2.9 54.0 ± 2.3 <0.001
Fly 19.3 ± 1.8 30.7 ± 2.5 19.1 ± 2.6 30.4 ± 2.1 18.0 ± 1.8 28.1 ± 2.1 <0.001
Shrugs 64.9 ± 9.9 96.9 ± 10.4 68.9 ± 11.2 103.9 ± 7.5 62.3 ± 6.9 100.5 ± 7.4 <0.001
Lateral Raises 12.6 ± 1.5 16.6 ± 1.7 11.4 ± 1.2 17.0 ± 1.5 13.0 ± 1.5 21.4 ± 2.9 <0.001
1All values (kg) are averages ± SEM; n = 9 for placebo, n = 9 for whey, n = 10 for soy.
2Pre = values are at baseline, prior to exercise and supplementation; post = end of 12 weeks.
3 Only the P value for the combined pre vs post data is shown, since diet had no significant effect and there was no interaction between diet and 
time (pre vs post).Journal of the International Society of Sports Nutrition 2009, 6:8 http://www.jissn.com/content/6/1/8
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mass gains is controversial [4,6,9,12,19]. We were most
interested, though in the potential for soy to have an
added benefit for groups at risk for cardiovascular disease.
Several studies have shown that soy reduces serum lipid
concentrations [16,18,31,32]. Coupled with our findings
and those of others [9,12,19] the combination of resist-
ance training and dietary manipulation, as part of long-
term lifestyle change, may reduce risk factors for cardio-
vascular disease by lowering body fat stores, increasing fat
free mass (an important determinant of metabolic rate),
[2,3]and improving blood lipid levels.
The absence of between-group differences in strength
gains between an animal-based protein supplement
(whey) and vegetable-based protein supplement (soy)
agrees with other studies examining the relationship
between different protein sources and improved strength
with resistance training. Phillips et al [10], in a study of
young, healthy men completing 12 weeks of resistance
training, found no significant differences in strength gains
between a milk-supplemented group, a soy protein-con-
taining group, and an energy control group. Haub et al
[13] examined different protein sources in combination
with 12 weeks of resistance training in older men. Their
subjects displayed increased strength, with no differences
between those who consumed a meat-containing diet
(57% of the protein source) versus a vegetable (soy)-
based diet (53% of the protein source). Strength gains
were similar among all groups in our study, indicating
that adequate protein rather than the protein source is
important in sustaining a positive nitrogen balance for
muscle accretion to occur. It should be noted that guiding
subjects in all groups to consume as close to 1.2 g/kg/day
of protein was to rule out confounding variables such as
an excess of protein in one or more comparisons groups
(i.e. the supplemented groups). While this was the intent,
it can't be ruled out that this may have brought all groups
to the threshold needed to gain lean body mass on a
resistance training program.
The finding of a significant decrease in total serum choles-
terol but no change in LDL-C, HDL-C or triglycerides and
no difference among groups is surprising. The benefits of
soy supplementation on improving lipid profiles are well
documented [16,31-33]. Zhan et al [32] completed a
meta-analysis on 23 randomized controlled trials investi-
gating the effects of soy protein containing isoflavones on
lipid profiles. The average study length in this review was
10.5 weeks. They concluded that soy protein with isofla-
vones significantly reduces total cholesterol, LDL choles-
terol and triglycerides and the magnitude of the effect was
related to the level and duration of supplement intake, to
the sex of the subjects and to initial serum lipid concentra-
tions. Anderson et al [18] also concluded that the effects
of soy on lipid profiles is most pronounced in hyercholes-
terolemic subjects when isoflavones in the soy supple-
ment ranged from 40 mg/day to greater than 80 mg/day.
The soy supplement in our study contained 56.2 mg of
isoflavones in the aglycone form. In a recent meta-analysis
of 41 randomized trials with an average study length of 10
weeks, Reynolds et al [34] found that soy supplementa-
tion was associated with a significant reduction in total
cholesterol, LDL cholesterol, and triglycerides (-5.26 mg/
dl, -4.25 mg/dl, -6.26 mg/dl respectively) and a significant
increase in HDL cholesterol (0.77 mg/dl). In a 2006
review, Torres et al [33] suggested that soy consumption
reduces the clinical and biochemical abnormalities in
lipid disorder-related diseases. In contrast, a study by Ma
et al [35], in which subjects consumed a milk protein sup-
plement or a soy protein supplement, found no treatment
effect on lipid profiles. The length of that particular study
was five weeks, which may not have been long enough to
observe an effect on serum lipid levels. It was surprising
that our subjects did not have a greater improvement in
serum lipids with the soy supplementation after 12 weeks.
A possible explanation may be individual differences in
the intestinal absorption of isoflavones. Equol is a
byproduct of the bio-transformation of the isoflavone
diadzein by microflora in the large intestine and is a
potent antioxidant [36]. Equol is not produced in the
same amount in all people in response to soy consump-
tion. It is estimated that the range of persons in the general
population that are classified as "equol producers" is 14–
70% [35,36], which could contribute to the variability of
Table 7: Fasting blood measures
PLACEBO1 WHEY1 SOY1 P Value
PRE POST PRE POST PRE POST PRE vs. POST2
Total Cholesterol (mg/dL) 209.4 ± 6.0 199.0 ± 8.8 220.3 ± 13.2 204.4 ± 6.0 211.7 ± 12.6 200.5 ± 11.6 0.012
HDL-C (mg/dL) 34.0 ± 2.2 31.1 ± 2.1 32.9 ± 2.1 32.0 ± 1.6 31.1 ± 3.4 32.8 ± 2.0 NS
Triglycerides (mg/dL) 109.0 ± 17.9 126.7 ± 12.8 104.0 ± 8.3 99.6 ± 18.1 139.0 ± 21.5 127.0 ± 12.9 NS
TC:HDL-C 6.4 ± 0.4 6.7 ± 0.6 7.0 ± 0.7 6.6 ± 0.5 7.1 ± 0.4 6.1 ± 0.3 NS
LDL-C direct:HDL-C 3.9 ± 0.3 4.0 ± 0.4 4.3 ± 0.4 4.1 ± 0.4 4.1 ± 0.3 3.7 ± 0.2 NS
1All values are averages ± SEM; n = 9 for placebo, n = 9 for whey, n = 10 for soy.
2 Only the P value for pre versus post is shown, with diet groups combined since the diet effects were not significant and there was no interaction 
between diet and time (pre versus post).
NS, P > 0.05Journal of the International Society of Sports Nutrition 2009, 6:8 http://www.jissn.com/content/6/1/8
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the effect of soy on serum lipids. The mechanisms respon-
sible for the isoflavone-effect on lipid profiles are not cur-
rently known but may be due to their biological similarity
to estrogens and estrogen-receptor-dependent genes
[14,32], to enhanced bile acid secretion [32], increasing
LDL receptor activity, or to enhancement of thyroxine and
thyroid-stimulating hormone [14,32].
The observation that serum triglycerides showed no sig-
nificant changes over the 12 weeks of the study is consist-
ent with previous studies [37,38]. But, subjects in the soy
group exhibited a trend toward reduction (lowered by
8.6% – versus a reduction in the whey group of 4.2% and
an increase in the control group of 16.2%). This trend sug-
gests that an intervention extending beyond 12 weeks may
result in significant changes. Indeed, other studies have
reported a beneficial effect of soy consumption alone on
serum triglycerides [18,33,34].
We attempted to eliminate diet changes other than inclu-
sion of assigned supplements. The percent of calories
derived from fat decreased significantly (p < 0.05) due to
the increase in energy from protein and carbohydrates in
spite of no change in total energy intake. It cannot be
ruled-out that the dietary fat content played a role in
improved lipid profiles but its role would be minor, at
best, in view of the fact that total energy and grams of fat
did not change significantly. The percent of energy from
protein was expected to increase in the whey and soy sup-
plemented groups. The reasons for the increased energy
from protein in the placebo group and for energy derived
from carbohydrates in all groups are unknown. Commu-
nity-living subjects may have naturally chosen to alter
their food choices and/or lifestyle based on their enthusi-
asm of improved health from participation in the study.
Study limitations
We may not have observed significant changes in body
composition and lipid profiles among the different pro-
tein supplements because of a type II error and it may be
that a longer (>12 weeks) training period is required to
show significant changes in body composition and in
lipid ratios such as TC:HDL-C and LDL-C:HDL-C. Meta-
analysis by Zhan et al [32] confirmed that improvements
in HDL cholesterol with soy protein supplementation
were only observed in studies > 12 weeks in duration. In
addition, a diet intervention (for example, limiting daily
fat calories to <25%) in combination with the resistance
training may have shown more dramatic results in body
composition and lipid profile changes. Another limita-
tion that may have affected the outcome of the study was
the difference in initial waist:hip. After randomized enrol-
ment it was observed the soy group had significantly
higher waist:hip than the other two groups. It may be that
the effect of soy was diminished because of this discrep-
ancy. It should be noted that individuals in the placebo
group did modify their diet and this included an increased
percentage of energy from protein and carbohydrate
sources and a decrease percent of calories from fat sources.
The results of training could also be due in part to these
diet changes, however; the changes in percent of energy
sources as noted in the placebo group do not typically
result in such dramatic increases in strength gains.
Conclusion
Our findings add to the growing evidence that resistance
training is beneficial for reducing cardiovascular risk. Our
results suggest that protein supplementation is not neces-
sary for strength or body composition changes in over-
weight men consuming a diet with an adequate supply of
amino acids to meet the needs for stimulation of muscle
protein synthesis during resistance exercise. Resistance
exercise training alone increases muscle mass and
improves body composition measures in sedentary, over-
weight men. Soy based protein supplements appear to be
as effective as animal-based protein to support strength
gains. Our results also suggest that soy protein supple-
mentation during resistance training warrants further
study in larger samples over longer periods of time since
previous work has shown that regular soy consumption
improves lipid profiles and the insulin-to-glucagon ratio
and lowers oxidative stress [3,16,17,31-34].
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